The clinical relevance of mild chronic anemia in patients after heart trans
plantation (HTX) has not yet been demonstrated. Forty-five outpatients who
had undergone HTX 2-99 months prior to investigation and who had not receiv
ed blood transfusions or erythropoietin (EPO) before data acquisition were
observed over a period of 37 months. Anemia was found in 36 of the 45 patie
nts and was normocytic, normochromic, and slightly anisocytotic (coefficien
t of variation = 16 rt 2, normal 11.5-14.5). Anemic patients showed elevate
d EPO levels, whereas in nonanemic patients EPO levels were normal. Surviva
l after HTX differed significantly in anemic and nonanemic patients (P < 0.
02), with 100 % survival in the nonanemic and 85 % in the anemic group. Chr
onic anemia in patients after HTX shows a typical pattern. Even when mild,
anemia in patients after HTX seems to be of prognostic value and thus might
be an indicator of chronic disorders.